Chemotherapy after surgery for thymic cancer
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You had surgery to remove thymic cancer within the last 3 months, and the entire tumor was removed.
- Your cancer is at stage I, II, or III (Masaoka staging).
- Your blood counts and organ function (liver, kidneys, heart, lungs) are in good shape.
- You do not have another active cancer, serious heart disease, or drug/alcohol addiction.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment given before surgery for people with advanced thymic carcinoma. It aims to shrink the tumor and make surgery more effective.
This trial tests combining surgery with heated chemotherapy delivered directly into the chest cavity for people whose thymus cancer has spread to the lining of the lung. The goal is to see if this approach is safe and effective.
This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.
This trial tests whether combining the immunotherapy drug adebrelimab with chemoradiation before surgery can help shrink locally advanced thymic carcinoma and improve outcomes. It is for people who have not yet received treatment for their thymic carcinoma.
This trial tests a shorter course of radiation therapy (hypofractionated) given after surgery for thymoma or thymic carcinoma. The goal is to see if this approach is safe and effective for people with stage I to III disease who need radiation after their thymus gland was removed.
This trial looks at adding radiation after a complete surgery to remove a thymoma (a tumor from the thymus) at stages II or III. It may help lower the chance the cancer comes back by treating leftover microscopic disease after surgery.
Hear when a new Thymic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.